Loading…
CIK 0001637946 • 6 13F filings • Apr 16, 2025 – Aug 17, 2026
Import this data to Google Sheets with:
=jivedata("general-catalyst-group-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| Amazon.com Inc. | COM | $925K | 0.5% | 3,882 SH | New |
| ArriVent BioPharma, Inc. | COM | $51.9M | 27.5% | 1,494,786 SH | New |
| Carvana Co | CL A | $426K | 0.2% | 6,465 SH | New |
| Coupang Inc. | CL A | $950K | 0.5% | 54,677 SH | New |
| Doordash Inc. | CL A | $526K | 0.3% | 2,850 SH | New |
| Eikon Therapeutics, Inc. | COM | $4.0M | 2.1% | 305,233 SH | New |
| Ethos Technologies, Inc. | CL A | $1.3M | 0.7% | 74,179 SH | New |
| Figma, Inc. | CLASS A COM STK | $269K | 0.1% | 14,845 SH | New |
| Fractyl Health, Inc. | COM | $3.9M | 2.1% | 4,884,186 SH | New |
| Maplebear, Inc. | COM | $33.7M | 17.9% | 710,711 SH | New |
| Maze Therapeutics, Inc. | COM | $30.9M | 16.4% | 1,035,910 SH | New |
| Meta Platforms Inc. | CL A | $744K | 0.4% | 1,320 SH | New |
| Odyssey Therapeutics, Inc. | COMMON STOCK | $15.2M | 8.0% | 810,272 SH | New |
| Parabilis Medicines, Inc. | COM | $43.8M | 23.2% | 1,600,937 SH | New |
| 13F-HR |
| 0001637946-26-000002 |
| $188.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000905148-25-002968 | $4.30B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000905148-26-002373 | $183.6M | View |
| Apr 16, 2025 | Q1 2025 | 13F-HR | 0000950123-25-003553 | $887.5M | View |